Brief report: Excitatory and inhibitory brain metabolites as targets of motor cortex transcranial direct current stimulation therapy and predictors of its efficacy in fibromyalgia

Arthritis and Rheumatology

Volumn 67, Issue 2, 2015, Pages 576-581

  Foerster, Bradley R ^a,b   Nascimento, Thiago D ^a   DeBoer, Misty ^a   Bender, Marycatherine A ^a   Rice, Indie C ^a   Truong, Dennis Q ^c   Bikson, Marom ^c   Clauw, Daniel J ^a   Zubieta, Jon Kar ^a   Harris, Richard E ^a   DaSilva, Alexandre F ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; AMINO ACID BRAIN LEVEL; ANTERIOR CINGULATE; ANTERIOR INSULA; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBROMYALGIA; HUMAN; LONGITUDINAL STUDY; MCGILL PAIN QUESTIONNAIRE; MIDDLE AGED; MOTOR CORTEX; NEUROCHEMISTRY; NEUROIMAGING; NEUROMODULATION; NEUROPATHOLOGY; NOCICEPTION; NUCLEAR MAGNETIC RESONANCE SCANNER; PAIN ASSESSMENT; POSTERIOR INSULA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSCRANIAL DIRECT CURRENT STIMULATION; VISUAL ANALOG SCALE; ANALOGS AND DERIVATIVES; BRAIN; CLINICAL TRIAL; METABOLISM; PAIN MEASUREMENT; PATHOLOGY; TREATMENT OUTCOME;

ADULT; ASPARTIC ACID; BRAIN; FEMALE; FIBROMYALGIA; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; MOTOR CORTEX; PAIN MEASUREMENT; PROTON MAGNETIC RESONANCE SPECTROSCOPY; TRANSCRANIAL DIRECT CURRENT STIMULATION; TREATMENT OUTCOME;

EID: 84922811075     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38945     Document Type: Article

References (21)

1. Gaskin DJ, Richard P,. The economic costs of pain in the United States. J Pain 2012; 13: 715-24.
2. Petrou M, Harris RE, Foerster BR, McLean SA, Sen A, Clauw DJ, et al. Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity. AJNR Am J Neuroradiol 2008; 29: 913-8.
3. Harris RE, Napadow V, Huggins JP, Pauer L, Kim J, Hampson J, et al. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology 2013; 119: 1453-64.
4. Gracely RH, Petzke F, Wolf JM, Clauw DJ,. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002; 46: 1333-43.
5. Harris RE, Sundgren PC, Craig AD, Kirshenbaum E, Sen A, Napadow V, et al. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 2009; 60: 3146-52.
6. Craig AD,. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002; 3: 655-66.
7. Foerster BR, Petrou M, Edden RA, Sundgren PC, Schmidt-Wilcke T, Lowe SE, et al. Reduced insular γ-aminobutyric acid in fibromyalgia. Arthritis Rheum 2012; 64: 579-83.
8. Aoki Y, Inokuchi R, Suwa H,. Reduced N-acetylaspartate in the hippocampus in patients with fibromyalgia: a meta-analysis. Psychiatry Res 2013; 213: 242-8.
9. Fregni F, Gimenes R, Valle AC, Ferreira MJ, Rocha RR, Natalle L, et al. A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum 2006; 54: 3988-98.
10. Marlow NM, Bonilha HS, Short EB,. Efficacy of transcranial direct current stimulation and repetitive transcranial magnetic stimulation for treating fibromyalgia syndrome: a systematic review. Pain Pract 2013; 13: 131-45.
11. O'Connell NE, Wand BM, Marston L, Spencer S, Desouza LH,. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev 2010; CD008208.
12. Jensen KB, Srinivasan P, Spaeth R, Tan Y, Kosek E, Petzke F, et al. Overlapping structural and functional brain changes in patients with long-term exposure to fibromyalgia pain. Arthritis Rheum 2013; 65: 3293-303.
13. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160-72.
14. Watson D, Clark LA, Tellegan A,. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988; 54: 1063-70.
15. Melzack R,. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 277-99.
16. Melzack R,. The short-form McGill Pain Questionnaire. Pain 1987; 30: 191-7.
17. Gandiga PC, Hummel FC, Cohen LG,. Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulation. Clin Neurophysiol 2006; 117: 845-50.
18. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK,. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005; 9: 463-84.
19. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R,. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998; 11: 266-72.
20. 1H magnetic resonance spectroscopy study. Neurosci Lett 2011; 500: 67-71.
21. Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012; 2012: 426130.